2020-11-16T15:55:10-06:00 2019-12-31 GRANT THORNTON LLP 1000 WILSON BLVD SUITE 1400 ARLINGTON VA 22209 990 2019-01-01 237311318 Drug Information Association Inc % BAYARD GARDINEER III DRUG 2154426100 21 Dupont Circle NW Suite 300 Washington DC 20036 BAYARD GARDINEER III Interim CFO 2154426126 2020-11-15 true Mary Torretta P00847851 7038477500 68.100.106.138 23695320203215000120 2020-11-16 P 67BB79B28DF85368BAF1697EF980A4E208353DD9 03CBAE45BD8E2F188EB28F31E827C7F4869431D2 2019 2021-01-29 14:40:06Z Barbara Lopez Kunz 21 Dupont Circle NW Suite 300 Washington DC 20036 26597788 false X www.diaglobal.org X 1964 MD See Schedule O 13 13 66 2500 364975 23410 0 0 23320631 23618071 270389 523966 23017 0 23614037 24142037 2400 7759 0 0 10041667 10338897 0 0 0 13412666 13668531 23456733 24015187 157304 126850 14815950 15523543 8958495 8385512 5857455 7138031 X See Schedule O false false 5429480 0 19629117 See Schedule O 1073320 0 2737839 See Schedule O 142365 0 364975 See Schedule O 11371432 7759 886140 All other program service expenses 11371432 7759 886140 18016597 true false false false false false false false false false true false false true false true false true false true true false false false false false false false true true false false false false false false false false false false false false true true true true false false true 110 0 true 66 true true true true CH IN JA SZ false false false false false false false false false false X 13 13 false false true false true false false true true false true true true true true true true true true true false X BAYARD GARDINEER III 2026018900 21 DUPONT CIRCLE NW SUITE 300 Washington DC 20036 Barbara Lopez Kunz Global Chief Executive 40.0 0.0 X 836091 0 35928 Sudip Parikh SR VP/Mng Dir of DIA Americas 40.0 0.0 X 445521 0 43823 Thomas Bols SVP/Managing Director EMEA 40.0 0.0 X 306742 0 59883 Tim Hess Global IT Director 40.0 0.0 X 239331 0 12659 Bill Allman Chief Digital Officer 40.0 0.0 X 212728 0 24585 Bayard Gardineer Chief Financial Officer 40.0 0.0 X 205064 0 14788 Linda Hee Jung Ko Associate Dir, Bus Development 40.0 0.0 X 181909 0 33299 Joy Whitlow Chief Financial Officer 40.0 0.0 X 176329 0 25028 Cathy Persedis Associate Dir, EMEA Operations 40.0 0.0 X 166697 0 22800 Sri Lakshmi Thiriveedh Controller 40.0 0.0 X 152864 0 36022 Alexander Eldridge IT Project Manager 40.0 0.0 X 156725 0 23589 Ozgur Kara Assoc Director, EMEA Finance 40.0 0.0 X 151021 0 27640 Ranjini Prithviraj Global Assc Dir Content Collab 40.0 0.0 X 150552 0 18142 Lorraine Risboskin Assc Dir Event Plng & Exhibits 40.0 0.0 X 148918 0 18023 Rebecca Vermeulen Chair 2.5 0.0 X X 0 0 0 Michael Romano Secretary/Treasurer 2.5 0.0 X X 0 0 0 Joseph Scheeren Past Chair 2.5 0.0 X 0 0 0 Lingshi Tan Chair Elect 1.25 0.0 X X 0 0 0 Elizabeth Garner Member 1.25 0.0 X 0 0 0 Angelika Joos Member 1.25 0.0 X 0 0 0 Tatyana Kosheleva Member 1.25 0.0 X 0 0 0 Judith Ng-Cashin Member 1.25 0.0 X 0 0 0 Michael Rosenblatt Member 1.25 0.0 X 0 0 0 Jonathan Sheldon Member 1.25 0.0 X 0 0 0 Peter Sorger Member 1.25 0.0 X 0 0 0 Kihito Takahashi Member 1.25 0.0 X 0 0 0 Cynthia Verst Member 1.25 0.0 X 0 0 0 Andrzej Czarnecki Member (end 6/2019) 1.25 0.0 X 0 0 0 Jeffrey Payne Member (end 6/2019) 2.5 0.0 X 0 0 0 Jay Roberts Member (end 6/2019) 1.25 0.0 X 0 0 0 3530492 0 396209 14 false true false CENTERPLATE SAN DIEGO CA 111 West Harbor Drive SAN DIEGO CA 92101 Hotel, F&B Services 575983 AV EXPERIENCE INC NA 825 - 43 AVENUE LACHINE QUEBEC CA H8T 2J6 Audio Visual Svcs 445524 J SPARGO ASSOCIATES INC 11208 WAPLES MILL ROAD SUITE 112 FAIRFAX VA 22030 Exhibits Expense 331684 Austria Centre Vienna INTENATIONALES AMTSITZ UND KONFEREN VIENNA 0 AU A-1220 A/V, Convention Ctr 315754 BETHESDA NORTH MARRIOTT PO BOX 402642 ATLANTA GA 303842642 Hotel, F&B Services 258385 12 0 MEETINGS AND WORKSHOPS 611710 19629117 19629117 0 0 TRAINING 611710 2737839 2737839 0 0 MEMBERSHIP DUES 900099 886140 886140 0 0 PUBLICATIONS 900004 364975 364975 0 23618071 296267 296267 0 0 0 0 0 2683450 2455751 227699 227699 227699 0 0 0 0 0 0 0 0 0 0 24142037 23253096 364975 523966 0 7759 7759 0 0 3043204 2282403 760801 0 5553832 4165374 1388458 445496 334122 111374 695157 521368 173789 601208 450906 150302 0 220567 165425 55142 149301 111976 37325 0 0 139213 104410 34803 454997 341248 113749 320405 240304 80101 287911 215933 71978 436220 327165 109055 0 676057 507043 169014 629080 471810 157270 0 98224 73668 24556 3859 2894 965 0 349668 262251 87417 88557 66418 22139 MEETINGS AND WORKSHOPS 7175652 5381739 1793913 0 TRAINING EXPENSES 1160443 870332 290111 0 DUES & SUBSCRIPTIONS 712314 534235 178079 0 CONSULTING EXPENSES 387483 290612 96871 0 378580 287202 91378 24015187 18016597 5998590 0 0 0 4222039 4107970 0 0 354049 586814 0 0 0 0 0 0 0 0 1448805 940983 3984502 3047539 777145 936963 6978627 7914633 0 0 0 0 0 0 1035285 1036180 14815950 15523543 3448539 2647013 0 0 5509956 5438499 0 0 0 0 0 0 0 0 0 300000 0 0 8958495 8385512 X 5857455 7138031 0 0 5857455 7138031 14815950 15523543 X 126850 1213940 -60214 X false true X true false X 0 0 0 0 0 0 22049411 21572283 22171029 23320631 23618071 112731425 0 0 0 22049411 21572283 22171029 23320631 23618071 112731425 0 0 0 112731425 700173 790575 792626 355266 296267 2934907 72906 55708 14871 42676 24410 210571 773079 846283 807497 397942 320677 3145478 -65321 -31338 -74607 -171266 8000 0 0 -26385 0 -18385 22765169 22387228 22903919 23692188 23938748 115687252 0.97445 0.96944 0.02719 0.03250 X 500532 235500 265032 3046705 2432215 614490 437265 379824 57441 936963 DUE FROM AFFILIATES 1016330 TENANT SECURITY DEPOSITS 19850 1036180 0 0 X ASC 740 (FIN48) Footnote SCHEDULE D, PART X, LINE 2 The Association has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ending December 31, 2019, 2018, 2017 and 2016 are still open to audit for both federal and state purposes. The Association has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements. Europe (Including Iceland and Greenland) 1 19 Program Services Meetings & Training 5050650 South Asia 4 22 Program Services Meetings & Training 5322503 5 41 5 41 10373153 10373153 true false true false false true true grants and awards 10 7759 Procedures for monitoring use of grant funds in the United States Schedule I, Part I, Line 2 FOR AWARDS DIA CONTINUES TO RECOGNIZE OUTSTANDING VOLUNTEERS FOR THEIR LEADERSHIP, LEVEL OF EXCELLENCE, AND COMMITMENT TO SERVICE. THIS CAN TAKE THE FORM OF AN HONORARY PAYMENT AND OR REIMBURSEMENT TO ATTEND A CONFERENCE OR MEETING IN WHICH THE AWARD IS GIVEN. FOR GRANTS DEPENDING ON THE USE OF FUNDS (E.G. EDUCATIONAL PROGRAMS, RESEARCH, MEETING ATTENDANCE, ETC.), EACH GRANTEE IS REQUIRED TO REPORT THE FOLLOWING: DETAILED PROGRAM CONTENT; NUMBER OF PARTICIPANTS; ONGOING RELEVANCE OF SUBJECT MATTER TO DIA'S MISSION; ACTUAL VS. PROPOSED TIMELINE; PROOF OF BUDGETARY ALLOCATION TO TIMELINE; REVISED TIMELINE FOR GRANT CYCLE; PROJECTED OUTCOME OF PROJECT; AND A FINAL REPORT ON THE OUTCOME OF THE PROJECT. X X X X false false false false false false false true false Barbara Lopez Kunz Global Chief Executive 630665 0 205426 0 0 0 16800 0 19128 0 872019 0 0 0 Bayard Gardineer Chief Financial Officer 106699 0 98365 0 0 0 6402 0 8386 0 219852 0 0 0 Joy Whitlow Chief Financial Officer 156329 0 20000 0 0 0 9380 0 15648 0 201357 0 0 0 Sudip Parikh SR VP/Mng Dir of DIA Americas 342913 0 102608 0 0 0 16800 0 27023 0 489344 0 0 0 Tim Hess Global IT Director 201364 0 37967 0 0 0 12002 0 657 0 251990 0 0 0 Bill Allman Chief Digital Officer 192728 0 20000 0 0 0 11564 0 13021 0 237313 0 0 0 Thomas Bols SVP/Managing Director EMEA 267822 0 38920 0 0 0 59883 0 0 0 366625 0 0 0 Linda Hee Jung Ko Associate Dir, Bus Development 181909 0 0 0 0 0 8442 0 24857 0 215208 0 0 0 Cathy Persedis Associate Dir, EMEA Operations 155144 0 11553 0 0 0 22800 0 0 0 189497 0 0 0 Sri Lakshmi Thiriveedhi Controller 142797 0 10067 0 0 0 9000 0 27022 0 188886 0 0 0 Alexander Eldridge IT Project Manager 143391 0 13334 0 0 0 8874 0 14715 0 180314 0 0 0 Ranjini Prithviraj Global Assc Dir Content Collab 138359 0 12193 0 0 0 8400 0 9742 0 168694 0 0 0 Ozgur Kara Assoc Director, EMEA Finance 138486 0 12535 0 0 0 27640 0 0 0 178661 0 0 0 Lorraine Risboskin Assc Dir Event Plng & Exhibits 136787 0 12131 0 0 0 8281 0 9742 0 166941 0 0 0 NON-FIXED PAYMENTS SCHEDULE J, PART I, LINE 7 BONUSES ARE DISCRETIONARY AND BASED ON A VARIETY OF PARAMETERS THAT MEET THE GOALS OF THE ORGANIZATION. Organization's mission Form 990, Part I, Line 1 and Part III, Line 1 DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES; - BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. Program Service Accomplishment 1 Form 990, Part III, Line 4a THE NUMBER OF MEETINGS, WORKSHOPS AND LEARNING HELD WORLDWIDE IN 2019 EXCEEDED 175. IN 2019, DIA CONDUCTED 160 WORKSHOPS AND TRAINING COURSES ALL OVER THE UNITED STATES WITH APPROX. 25,000 PARTICIPANTS. IN ADDITION TO THESE EVENTS, THE DIA ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED OVER 7,000 PARTICIPANTS FROM THE U.S AND ACROSS THE WORLD. IN 2019, DIA CONDUCTED 82 WORKSHOPS AND TRAINING COURSES ACROSS EUROPE, ATTRACTING OVER 1,859 PARTICIPANTS. IN ADDITION, THE ANNUAL DIA EUROPEAN ANNUAL MEETING, WHICH ATTRACTED OVER 755 PARTICIPANTS, IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY. IN 2019, DIA CONDUCTED 18 EDUCATIONAL EVENTS IN JAPAN, ATTRACTING OVER 2,400 PARTICIPANTS FROM JAPAN AND OTHER COUNTRIES. IN 2019, ADDITIONALLY THE DIA JAPAN ANNUAL MEETING ATTRACTED OVER 1,274 ATTENDEES. IN 2019 DIA CONDUCTED 19 EVENTS IN CHINA, ATTRACTING OVER 3,895 PARTICIPANTS. THE DIA CHINA ANNUAL MEETING ATTRACTED OVER 2,900 ATTENDEES. IN 2019, DIA CONDUCTED 8 EVENTS IN INDIA, ATTRACTING OVER 500 PARTICIPANTS. IN 2019, DIA CONDUCTED 2 EVENTS IN THE REST OF THE WORLD, ATTRACTING 400 PARTICIPANTS. WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS LEARNING IN ELECTRONIC FORMAT. IN 2019, DIA HAD 2,603 ELEARNERS INCLUDING BOTH INDIVIDUALS AND GROUPS. Program Service Accomplishment 2 Form 990, Part III, Line 4b Learning: In 2019, DIA conducted training courses across the globe. With an on-going commitment to internet technology-based learning, DIA continued to expand its global reach and advance its mission by offering various workshops in electronic format. In 2019, DIA had 2,603 elearners including both individuals and groups. Program Service Accomplishment 3 Form 990, Part III, Line 4c PUBLICATIONS: THERAPEUTIC INNOVATION & REGULATORY SCIENCE PUBLICATION (TIRS) IS THE OFFICIAL JOURNAL OF DIA. ITS MISSION IS TO ADVANCE HEALTHCARE PRODUCT DISCOVERY, DEVELOPMENT, REGULATION, AND USE THROUGH THE PUBLICATION OF PEER-REVIEWED ARTICLES AND COMMENTARIES ACROSS THE SPECTRUM OF CONVERTING BIOMEDICAL SCIENCE INTO PRACTICAL SOLUTIONS TO ADVANCE HUMAN HEALTH. IT IS PUBLISHED IN ODD NUMBER MONTHS, JANUARY, MARCH, MAY, JULY, SEPTEMBER, AND NOVEMBER. DIA ALSO PUBLISHES THE GLOBAL FORUM, ANOTHER E-PUBLICATION. IT OFFERS EXPERT GLOBAL AND REGIONAL COVERAGE OF DISCOVERY, DEVELOPMENT, REGULATION, SURVEILLANCE, AND MARKETING OF HEALTHCARE PRODUCTS, INCLUDING INTERVIEWS WITH LEADERS AND TOPICAL SUMMARIES FROM EDUCATIONAL EVENTS. IT IS PUBLISHED MONTHLY. Other Program Service Accomplishments FORM 990, PART III LINE 4D DIA PROVIDES PROGRAMS TO DEVELOP, STRENGTHEN, AND SUPPORT COLLABORATION WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE STAKEHOLDERS. CHANGES TO ORGANIZATIONAL DOCUMENTS FORM 990, PART VI, SECTION A, LINE 4 THE ORGANIZATION AMENDED ITS ELECTION PROCEDURES IN ITS BYLAWS - OFFICERS AND DIRECTORS SHALL NOW BE ELECTED BY MEMBERS OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH THESE BYLAWS. MEMBERS OR STOCKHOLDERS FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. FORM 990 REVIEW PROCESS FORM 990, PART VI, SECTION B, LINE 11B IRS FORM 990 IS PREPARED AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM. A DRAFT IS THEN JOINTLY REVIEWED BY THE PRESIDENT & GLOBAL CHIEF EXECUTIVE, THE CFO AND THE BOARD TREASURER/FINANCE COMMITTEE CHAIR. AFTER THIS REVIEW AND APPROVAL, A COMPLETE COPY OF THE FORM 990 IS PROVIDED TO THE BOARD AS FILED WITH THE IRS. CONFLICT OF INTEREST POLICY MONITORING AND ENFORCEMENT FORM 990, PART VI, SECTION B, LINE 12C PERIODICALLY, MANAGEMENT EVALUATES EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. Every year, all board members complete and sign a confidentiality agreement to maintain conflict of interest policy. PROCESS USED TO DETERMINE EXECUTIVE COMPENSATION FORM 990, PART VI, SECTION B, LINES 15A & 15B ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL UPPER MANAGEMENT LEVEL EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE COMPENSATION COMMITTEE OBTAINS AND RELIES UPON COMPARABLE DATA IN THE SAME OR SIMILAR COMMUNITIES FOR SIMILAR SERVICES. THE REVIEW PROCESS AND BASIS FOR COMPENSATION PACKAGES IS ADEQUATELY DOCUMENTED. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A PERFORMANCE AND COMPENSATION REPORT. HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. OTHER CHANGES IN NET ASSETS & FUND BALANCES FORM 990, PART XI, LINE 9 Foreign Currency Exchange Loss $(60,214) DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 Drug Edu PA 0 1335739 DIA Inc DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 Drug Edu PA 10 449956 DIA Inc DIA LEARNING LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 475438125 Drug Edu PA 793896 1780090 DIA Inc DIA(INDIA) PRIVATE LIMITED UNIT 250 TIMES SQUAREANDHERI EAST Mumbai IN 400059 Scientific Ed IN DIA INC PRIVATE LTD 125601 62480 1.00000 true DIA EUROPE GMBH KUECHENGASSE 16 POSTAFACH Basel SZ 4002 Scientific Ed SZ DIA INC LLC 0 166772 1.00000 true DIA E-LEARNING EUROPE GMBH KUECHENGASSE 16 POSTAFACH Basel SZ 4002 Scientific Ed SZ DIA INC LLC 0 11335 1.00000 true DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA Beijing CH Scientific Ed CH DIA Global Hlth PRIVATE LLC 3067977 656467 1.00000 true SH DIA JAPAN NIHONBASHI LIFE SCI BLDG 6F Tokyo JA Scientific Ed JA DIA LLC GIC 1704599 3829677 1.00000 true DIA (SHANGHAI) HEALTHCARE INFORMATION SHANGHAI Shanghai CH Scientific Ed CH DIA Global Hlth PRIVATE LLC 190472 30799 1.00000 true false false false false false false false false false false false true true true false true false true true DIA India r 35000 cash